Crystal-associated arthritis in the elderly

Clinics in Geriatric Medicine

Volumn 21, Issue 3 SPEC. ISS., 2005, Pages 491-511

  Wise, Christopher M ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; APATITE; CALCIUM PHOSPHATE; COLCHICINE; CREATININE; CYCLOOXYGENASE 2 INHIBITOR; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROBENECID; THIAZIDE DIURETIC AGENT; URIC ACID;

ARTHROPATHY; BONE MARROW SUPPRESSION; CHONDROCALCINOSIS; CLINICAL FEATURE; COMORBIDITY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; EDEMA; GASTROINTESTINAL TOXICITY; GOUT; HUMAN; HYPERTENSION; HYPERURICEMIA; HYPOURICEMIA; INTERPHALANGEAL JOINT; JOINT RADIOGRAPHY; KIDNEY FAILURE; KIDNEY FUNCTION; METATARSOPHALANGEAL JOINT; MONARTHRITIS; NEPHROTOXICITY; POLYARTHRITIS; PSEUDOGOUT; REVIEW; SYNOVIAL FLUID; THROMBOCYTE DYSFUNCTION; URIC ACID BLOOD LEVEL; URINARY EXCRETION;

EID: 19344365992     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2005.02.003     Document Type: Review

References (103)

1. D.J. McCarty, and J.L. Hollander Identification of urate crystals in gouty synovial fluids Ann Intern Med 54 1961 452 460
2. D.J. McCarty, N.N. Kohn, and J.S. Faires The significance of calcium phosphate crystals in the synovial fluid of arthritis patients: the "pseudogout syndrome." I. Clinical aspects Ann Intern Med 56 1962 711 737
3. C. Schiltz, F. Liote, and F. Prudhommeaux Monosodium urate monohydrate crystal-induced inflammation in vivo: quantitative histomorphometric analysis of cellular events Arthritis Rheum 46 6 2002 1643 1650
4. R.C. Landis, D.R. Yagnik, and O. Florey Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages Arthritis Rheum 46 11 2002 3026 3033
5. D.R. Yagnik, P. Hillyer, and D. Marshall Noninflammatory phagocytosis of monosodium urate monohydrate crystals by mouse macrophages. Implications for the control of joint inflammation in gout Arthritis Rheum 43 2000 1779 1789
6. R. Roubenoff Gout and hyperuricemia Rheum Dis Clin North Am 16 1990 539 550
7. R.D. Abbott, F.N. Brand, and W.B. Kannel Gout and coronary artery disease. The Framingham study J Clin Epidemiol 41 1988 237 242
8. E. Arromdee, C.J. Michet, and C.S. Crowson Epidemiology of gout: Is the incidence rising? J Rheumatol 29 11 2002 2403 2406
9. K.L. Wallace, A.A. Riedel, N. Joseph-Ridge, and R. Wortmann Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population J Rheumatol 31 8 2004 1582 1587
10. K.H. Yu, and S.F. Luo Younger age of onset of gout in Taiwan Rheumatology (Oxford) 42 1 2003 166 170
11. R.C. Lawrence, M.C. Hochberg, and J.L. Kelsey Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States J Rheumatol 16 1989 427 441
12. R.C. Lawrence, C.G. Helmick, and F.C. Arnett Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States Arthritis Rheum 41 5 1998 778 799
13. J.D. Bieber, and R.A. Terkeltaub Gout: on the brink of novel therapeutic options for an ancient disease Arthritis Rheum 50 8 2004 2400 2414
14. M.C. Hochberg, J. Thomas, and D.J. Thomas Racial differences in the incidence of gout Arthritis Rheum 38 1995 628 632
15. D.G. MacFarlane, and P.A. Dieppe Diuretic-induced gout in elderly women Br J Rheumatol 24 1985 155 157
16. E. Ter Borg, and J. Rasker Gout in the elderly, a separate entity? Ann Rheum Dis 46 1987 72 76
17. R.L. Wortmann, and W.N. Kelley Gout and hyperuricemia S. Ruddy E.D. Harris C.B. Sledge Textbook of rheumatology 2001 Saunders Philadelphia 1339 1376
18. E.S. Campion, R.J. Glynn, and L.O. DeLabry Asymptomatic hyperuricemia: risks and consequences in the Normative Aging Study Am J Med 82 1987 421 426
19. K.C. Lin, H.M. Tsao, C.H. Chen, and P. Chou Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia J Rheumatol 31 6 2004 1152 1158
20. R.J. Johnson, D.H. Kang, and D. Feig Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41 6 2003 1183 1190
21. H.K. Choi, K. Atkinson, and E.W. Karlson Purine-rich foods, dairy and protein intake, and the risk of gout in men N Engl J Med 350 11 2004 1093 1103
22. H.K. Choi, K. Atkinson, and E.W. Karlson Alcohol intake and risk of incident gout in men: a prospective study Lancet 363 9417 2004 1277 1281
23. N.A. Shadick, R. Kim, and S. Weiss Effect of low level lead exposure on hyperuricemia and gout among middle aged and elderly men: the normative aging study J Rheumatol 27 2000 1708 1712
24. J.L. Lin, D.T. Tan, H.H. Ho, and C.C. Yu Environmental lead exposure and urate excretion in the general population Am J Med 113 7 2002 563 568
25. J.T. Scott, and C.S. Higgins Diuretic induced gout: a multifactorial condition Ann Rheum Dis 51 1992 259 261
26. J.B. Wilk, L. Djousse, and I. Borecki Segregation analysis of serum uric acid in the NHLBI Family Heart Study Hum Genet 106 3 2000 355 359
27. N.M. Hadler, W.A. Franck, N.M. Bress, and D.R. Robinson Acute polyarticular gout Am J Med 56 1974 715 719
28. G.V. Lawry, P.G. Fan, and R. Bluestone Polyarticular versus monoarticular gout: a prospective comparative analysis of clinical features Medicine 67 1988 335 343
29. D.A. Raddatz, M.L. Mahowald, and P.J. Bilka Acute polyarticular gout Ann Rheum Dis 42 1983 117 120
30. M. Doherty, and P. Dieppe Crystal deposition in the elderly Clin Rheum Dis 12 1986 97 116
31. K.L. Sewell, R. Petrucci, and H.D. Keiser Misdiagnosis of rheumatoid arthritis in an elderly woman with gout J Am Geriatr Soc 39 1991 403 406
32. J.G. Puig, A.D. Michan, and M.L. Jimenez Female gout: clinical spectrum and uric acid metabolism Arch Intern Med 151 1991 726 732
33. Y.B. Park, Y.S. Park, and J. Song Clinical manifestations of Korean female gouty patients Clin Rheumatol 19 2 2000 142 146
34. A.G. Fam, J. Stein, and J. Rubenstein Gouty arthritis in nodal osteoarthritis J Rheumatol 23 1996 684 689
35. E.V. Lally, B. Zimmermann, G. Ho Jr, and S.R. Kaplan Urate-mediated inflammation in nodal osteoarthritis: clinical and roentgenographic correlations Arthritis Rheum 32 1989 86 90
36. R.H. Shmerling, S.H. Stern, and E.M. Gravallese Tophaceous deposition in the finger pads without gouty arthritis Arch Intern Med 148 1988 1830 1832
37. P.A. Simkin, P.M. Campbell, and E.B. Larson Gout in Heberden's nodes Arthritis Rheum 26 1983 94 97
38. R. Wernick, C. Winkler, and S. Campbell Tophi as the initial manifestation of gout: report of six cases and review of the literature Arch Intern Med 152 1992 873 876
39. N.W. Holland, D. Jost, and A. Beutler Finger pad tophi in gout J Rheumatol 23 4 1996 690 692
40. J.H. Gurwitz, S.C. Kalish, and R.L. Bohn Thiazide diuretics and the initiation of anti-gout therapy J Clin Epidemiol 50 8 1997 953 959
41. D.A. Nakayama, C. Barthelemy, and G. Carrera Tophaceous gout: a clinical and radiographic assessment Arthritis Rheum 27 1984 468 471
42. C.A. Agudelo, A. Weinberger, and H.R. Schumacher Definitive diagnosis of gout by identification of urate crystals in asymptomatic metatarsophalangeal joints Arthritis Rheum 22 1979 559 560
43. E. Pascual, E. Batlle-Gualda, and A. Martinez Synovial fluid analysis for diagnosis of intercritical gout Ann Intern Med 131 10 1999 756 759
44. K.H. Yu, S.F. Luo, and L.B. Liou Concomitant septic and gouty arthritis-an analysis of 30 cases Rheumatology (Oxford) 42 9 2003 1062 1066
45. B.T. Emmerson The management of gout N Engl J Med 334 1996 445 451
46. C.A. Agudelo, and C.M. Wise Crystal deposition diseases M.H. Weisman M.E. Weinblatt J. Louie Treatment of rheumatic disease 2001 Saunders Philadelphia 447 460
47. R.A. Terkeltaub Clinical practice. Gout N Engl J Med 349 17 2003 1647 1655
48. A.G. Fam Gout in the elderly. Clinical presentation and treatment Drugs Aging 13 3 1998 229 243
49. W.N. Roberts, M.H. Liang, and S.H. Stern Colchicine in acute gout: reassessment of risks and benefits JAMA 257 1987 1920 1922
50. S.L. Wallace, and J.Z. Singer Systemic toxicity associated with the intravenous administration of colchicine-guidelines for use J Rheumatol 15 1988 495 499
51. R.A. Bonnel, M.L. Villalba, C.B. Karwoski, and J. Beitz Deaths associated with inappropriate intravenous colchicine administration J Emerg Med 22 4 2002 385 387
52. M.R. Griffen, J.M. Piper, and J.R. Daugherty Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons Ann Intern Med 114 1991 257 263
53. J.H. Gurwitz, J. Avorn, and D. Ross-Degnan Nonsteroidal anti-inflammatory drug-associated azotemia in the very old JAMA 264 1990 471 475
54. A.G. Fam Treating acute gouty arthritis with selective COX 2 inhibitors BMJ 325 7371 2002 980 981
55. J.A. Alloway, M.J. Moriarty, and Y.T. Hoogland Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis J Rheumatol 20 1993 111 113
56. D. Axelrod, and S. Preston Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout Arthritis Rheum 31 1988 803 805
57. A.G. Fam Current therapy of acute microcrystalline arthritis and the role of corticosteroids J Clin Rheumatol 3 1997 35 40
58. G.D. Groff, W.A. Franck, and D.A. Raddatz Systemic steroid therapy for acute gout Semin Arthritis Rheum 19 1990 329 336
59. J. Ritter, J.D. Kerr, and J. Valeriano-Marcet ACTH revisited: effective treatment for acute crystal induced synovitis in patients with multiple medical problems J Rheumatol 21 1994 696 699
60. D.W. Roane, M.D. Harris, and M.T. Carpenter Prospective use of intramuscular triamcinolone acetonide in pseudogout J Rheumatol 24 1997 1168 1170
61. L.B. Siegel, J.A. Alloway, and D.J. Nashel Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis J Rheumatol 21 1994 1325 1327
62. C. Fernandez, A. Noguera, and J.A. Gonzalez Treatment of acute attacks of gout with a small dose of intraarticular triamcinolone acetonide J Rheumatol 26 10 1999 2285 2286
63. R.W. Kuncl, G. Duncan, and D. Watson Colchicine myopathy and neuropathy N Engl J Med 316 1987 1562 1568
64. S.L. Wallace, J.Z. Singer, and G.L. Duncan Renal function predicts colchicine toxicity; guidelines for the prophylactic use of colchicine in gout J Rheumatol 18 1992 264 269
65. E.B. Gonzalez, S.B. Miller, and C.A. Agudelo Optimal management of gout in older persons Drugs Aging 4 1994 128 134
66. P.A. Simkin When, why, and how should we quantify the excretion rate of urinary uric acid? J Rheumatol 28 6 2001 1207 1210
67. A.G. Fam Gout, diet, and the insulin resistance syndrome J Rheumatol 29 7 2002 1350 1355
68. M.L. Snaith Gout: diet and uric acid revisited Lancet 358 9281 2001 525
69. V. Bautman, J.K. Maesako, and B. Haddad The role of lead in gout nephropathy N Engl J Med 304 1981 520 523
70. D. Caspi, E. Lubart, and E. Graff The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients Arthritis Rheum 43 2000 103 108
71. F. Perez-Ruiz, M. Calabozo, and A.M. Herrero-Beites Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts Nephron 86 3 2000 287 291
72. C.J. Michet, J.M. Evans, and K.C. Fleming Common rheumatologic diseases in the elderly Mayo Clin Proc 70 1995 1205 1214
73. A. Shoji, H. Yamanaka, and N. Kamatani A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy Arthritis Rheum 51 3 2004 321 325
74. P.W. Bull, and J.T. Scott Intermittent control of hyperuricemia in the treatment of gout J Rheumatol 16 1989 1246 1248
75. F. Perez-Ruiz, M. Calabozo, and M.J. Fernandez-Lopez Treatment of chronic gout in patients with renal function impairment: an open, randomized, actively controlled study J Clin Rheumatol 5 1999 49 55
76. M.D. Feher, A.L. Hepburn, and M.B. Hogarth Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout Rheumatology (Oxford) 42 2 2003 321 325
77. S. Takahashi, Y. Moriwaki, and T. Tamamoto Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism Ann Rheum Dis 62 6 2003 572 575
78. K.R. Hande, R.M. Noone, and W.J. Stone Severe allopurinol toxicity: description and guidelines for prevention in patients with renal insufficiency Am J Med 76 1984 47 56
79. P. Smith, N. Karlson, and B.R. Nair Quality use of allopurinol in the elderly J Qual Clin Pract 20 1 2000 42 43
80. A.A. Riedel, M. Nelson, and N. Joseph-Ridge Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims J Rheumatol 31 8 2004 1575 1581
81. A.G. Fam, S.M. Dunne, and J. Iazzetta Efficacy and safety of desensitization to allopurinol following cutaneous reactions Arthritis Rheum 44 2001 231 238
82. A.J. Reginato, and A.M. Reginato Diseases associated with deposition of calcium pyrophosphate or hydroxyapatite S. Ruddy E.D. Harris C.B. Sledge Textbook of rheumatology 2001 WB Saunders Philadelphia (PA) 1377 1390
83. J. Hirose, L.M. Ryan, and I. Masuda Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease Arthritis Rheum 46 12 2002 3218 3229
84. L.M. Ryan, and H.S. Cheung The role of crystals in osteoarthritis Rheum Dis Clin N Am 25 1999 257 267
85. K. Jaovisidha, and A.K. Rosenthal Calcium crystals in osteoarthritis Curr Opin Rheumatol 14 3 2002 298 302
86. S. Nalbant, J.A. Martinez, and T. Kitumnuaypong Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies Osteoarthritis Cartilage 11 1 2003 50 54
87. M.P. Morgan, and G.M. McCarthy Signaling mechanisms involved in crystal-induced tissue damage Curr Opin Rheumatol 14 3 2002 292 297
88. E. Wilkins, P. Dieppe, and P. Maddison Osteoarthritis and articular chondrocalcinosis in the elderly Ann Rheum Dis 42 1983 280 284
89. R.L. Neame, A.J. Carr, and K. Muir UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte Ann Rheum Dis 62 6 2003 513 518
90. A.E. Timms, Y. Zhang, and R.G. Russell Genetic studies of disorders of calcium crystal deposition Rheumatology (Oxford) 41 7 2002 725 729
91. H.R.J. Schumacher Hemochromatosis and arthritis Arthritis Rheum 7 1964 41 50
92. E.C. Tanglao, M.A. Stern, and C.A. Agudelo Arthropathy as the presenting symptom in hereditary hemochromatosis Am J Med Sci 312 1996 306 309
93. R. Faraawi, M. Harth, and A. Kertesz Arthritis in hemochromatosis J Rheumatol 20 1993 448 452
94. D.J. McCarty Diagnostic mimicry in arthritis: patterns of joint involvement associated with calcium pyrophosphate dihydrate crystals Bull Rheum Dis 25 1975 1438 1440
95. G.J. Ho, and M. DeNuccio Gout and pseudogout in hospitalized patients Arch Intern Med 153 1993 2787 2790
96. D. Bona, and R. Bennett Pseudogout mimicking systemic disease JAMA 246 1981 1438 1440
97. A. Alvarellos, and I. Spilberg Colchicine prophylaxis in pseudogout J Rheumatol 13 1986 804 805
98. B. Rothschild, and L.E. Yakaobov Prospective 6 month double blind trial of hydroxychloroquine treatment of CPPD Compr Ther 23 1997 327 330
99. E.S. Molloy, and G.M. McCarthy Hydroxyapatite deposition disease of the joint Curr Rheumatol Rep 5 3 2003 215 221
100. P.B. Halverson, G.F. Carrera, and D.J. McCarty Milwaukee shoulder syndrome: fifteen additional cases and a description of contributing factors Arch Intern Med 150 1990 677 682
101. D.L. McCarty, P.B. Halverson, and C.F. Carrera "Milwaukee shoulder"-association of microspheroids containing hydroxyapatite crystals, active collagenase, and neutral protease with rotator cuff defects. I. Clinical aspects Arthritis Rheum 24 1981 464 473
102. P.B. Halverson Crystal deposition disease of the shoulder (including calcific tendonitis and milwaukee shoulder syndrome) Curr Rheumatol Rep 5 3 2003 244 247
103. J. Antoniou, A. Tsai, and D. Baker Milwaukee shoulder: correlating possible etiologic variables Clin Orthop 407 2003 79 85